-+ 0.00%
-+ 0.00%
-+ 0.00%

Aptevo Therapeutics Expands Oncology Pipeline with Launch of Trispecific CD3-Directed Anti-Cancer Molecules APVO452 and APVO451

Reuters·09/04/2025 12:45:33

Please log in to view news